Understanding and harnessing gut microbiome to enable healthy longevity

Moonshot Goal 7

Development by 2040 of a sustainable medical and nursing care system that prevents and overcomes major diseases thereby enabling healthy longevity until the age of 100. 

Understanding and harnessing gut microbiome to enable healthy longevity

This project comprises of four interacting teams, 1. The Gut Microbiota Metabolite Discovery Team (Sugiura, Arita, Suematsu, Inoue), 2. The Longevity-Associated Microbiome Team (Arai, Atarashi, Tuganbaev), 3. The Gut-Brain Axis Team (Yuzaki, Imayoshi, Sasaki, Nakae), and 4. The Chronic Inflammation Control Team (Ohno, Takeda, Shinkura). Through seamless collaboration among these four teams, this project aims to elucidate the roles and functions of microbiota-derived metabolites and their synergistic effects on the host in three key areas, i.e., healthy longevity, chronic inflammation, and gut-brain interaction, by investigating the intestinal microbiota of centenarians, pre-centenarians, as well as patients suffering from inflammatory bowel disease, cognitive disorders, and Parkinson's disease.

By 2030, we shall achieve the following four key objectives: 1) Enhance our comprehension of the structural and functional attributes of metabolites derived from gut bacteria, 2) Elucidate the characteristics and functions of intestinal microbes and metabolites in centenarians, 3) Illuminate the molecular and cellular basis of the gut-brain axis, and 4) Devise efficacious techniques to regulate chronic inflammation through gut microbiota intervention, thereby promoting healthy longevity.